Making Treatment-Free Remission (TFR) Easier in Chronic Myeloid Leukemia: Fact-Checking and Practical Management Tools

In chronic-phase chronic myeloid leukemia (CML), tyrosine kinase inhibitors (TKIs) are the standard of care, and treatment-free remission (TFR) following the achievement of a stable deep molecular response (DMR) has become, alongside survival, a primary goal for virtually all patients. The GIMEMA CM...

Descripción completa

Detalles Bibliográficos
Autores principales: Castagnetti, Fausto, Binotto, Gianni, Capodanno, Isabella, Billio, Atto, Calistri, Elisabetta, Cavazzini, Francesco, Crugnola, Monica, Gozzini, Antonella, Gugliotta, Gabriele, Krampera, Mauro, Lucchesi, Alessandro, Merli, Anna, Miggiano, Maria Cristina, Minotto, Claudia, Poggiaspalla, Monica, Salvucci, Marzia, Scappini, Barbara, Tiribelli, Mario, Trabacchi, Elena, Rosti, Gianantonio, Galimberti, Sara, Bonifacio, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Therapy in Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613078/
https://www.ncbi.nlm.nih.gov/pubmed/34661826
http://dx.doi.org/10.1007/s11523-021-00831-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613078/
https://www.ncbi.nlm.nih.gov/pubmed/34661826
http://dx.doi.org/10.1007/s11523-021-00831-4

Ejemplares similares